Практичні аспекти бактеріального вагінозу: актуальність, діагностика та комплексне лікування

Abstract

Bacterial vaginosis (BV) is significantly widespread in the population: its detection rate in women with inflammatory diseases of the urinary system is 35%, among pregnant women – 10-30%, among patients with sexually transmitted infection – 20-60%. The presence of BV leads to pregnancy complications, after gynecological surgery and the development of relapses of the disease. To achieve a full therapeutic effect, it is necessary not only to conduct antimicrobial therapy, but also to restore the vaginal biocenosis, which is a condition for preventing relapse. A two-stage treatment for BV was studied using Limenda and Bioselak. The use of the combined antimicrobial drug Limenda at the first stage of treatment of BV showed a high clinical effect (100%) with confirmation of cure according to microscopic examination (97.9%). But after the completion of antimicrobial therapy, only in 29.2% of cases the restoration of the rod vaginal microflora was noted. The local use of the probiotic Bioselak at the second stage of treatment ensured the restoration of the biocenosis in all patients (100%) and a long relapse-free period. The high clinical effectiveness of the proposed scheme allows us to recommend it for the treatment of BV and the prevention of relapse. Key words: bacterial vaginosis, vaginal biocenosis, relapse prevention, local probiotic, Limenda, Bioselak.